SCOTUS Upholds Mifepristone Access
In a unanimous decision, the U.S. Supreme Court preserved widespread access to the abortion pill mifepristone, rejecting a major challenge to the FDA's regulations on June 13, 2024. This critical ruling ensures the drug, used in nearly two-thirds of U.S. abortions, remains available under its current rules because the anti-abortion groups lacked legal standing to sue.